October 15, 2026 marked the 3rd annual Lobular Breast Cancer Awareness Day, and the final day of the Lobular Breast Cancer Awareness Tour. Organizations worldwide hosted in-person gatherings, educational seminars, and virtual sessions to raise awareness of ILC.
U.S. Events and Actions
California: Cancer Support Community Valley/Ventura/Santa Barbara hosted a Lobular Breast Cancer Awareness Day Social organized by LBCA patient advocate, Janet Lapins.
Colorado: University of Colorado Anschutz held an in-person gathering featuring research updates, laboratory tours, networking opportunities, a poster session, and a catered lunch for registered guests, organized by LBCA SAB member, Dr. Matthew Sikora.
Maryland: LBCA sponsored the Johns Hopkins Medicine Surgery Grand Rounds inaugural ILC guest lecture for general surgeons titled “Lobular Breast Cancer: Past, Present, and Future,” presented by LBCA SAB member and co-lead of the Memorial Sloan Kettering ILC Program, breast surgeon, Dr. Anita Mamtani.
Massachusetts: Dana-Farber Cancer Institute’s 2-year old ILC program, which launched on October 15, 2024, led by SAB members, Drs. Rinath Jeselsohn and Kristina Fanucci, hosted an ILC awareness and education event for the public followed by a luncheon and tour of Dr. Jeselsohn’s lab. State Representative Michelle Badger was on hand to present Massachusetts Governor Healey’s proclamation that October 15, 2026 is Lobular Breast Cancer Awareness Day.
Ohio: Cleveland Clinic Director of Breast Medical Oncology, head of the ILC program, and LBCA SAB member Dr. Megan Kruse, hosted an educational event for patients and community members to learn more about ILC. Scientists and clinicians reviewed the basics of lobular pathology and highlighted ongoing ILC research. Dr. Kruse also described evolving approaches to clinical care for patients with lobular breast cancer.
Texas: LBCA sponsored UT Health San Antonio Mays Cancer Center’s second annual ILC guest lectureship to a physician-focused Grand Rounds titled “Bridging Stress Biology & Metabolism in Invasive Lobular Breast Cancer,” presented by LBCA SAB member, Dr. Rebecca Riggins.
International Events and Actions
Australia: University of Queensland Frazer Institute hosted an in-person talk and lab tour, while MBC Action Australia presented a webinar exploring metastatic invasive lobular carcinoma (mILC) advances in research, imaging, and treatment, featuring LBCA SAB member Dr. Peter Simpson as a presenter and LBCA Patient Advocate Advisory Board member, Kristen Elsby as host.
Brazil: Brazilian Group for Breast Cancer Studies (GBECAM) held a special edition of their online scientific meeting, GBECAM Connection. Highlights included a discussion on the biology of ILC and its clinical implications, a presentation on aggressive ILC variants, and a multidisciplinary case discussion.
Canada: Toronto Stock Exchange / TMX Group held a special stock market closing event, and LBCA Board of Directors member, Brenda Cunnington hosted a presentation featuring speakers Dr. Christine Brezden-Masley, Dr. Sean Egan, and Kimberly Carson, CEO of Breast Cancer Canada.
France: Institut des Cancers des Femmes at Institut Curie hosted a public webinar covering ILC diagnosis, research advances, and patient testimony for patients, professionals, and the public.
Netherlands: Stitching Lobulair Borstkanker held an awareness and education conference in Amsterdam initiated by Antoni van Leeuwenhoek, Erasmus MC, Maastricht UMC+, and UMC Utrecht.
United Kingdom: Lobular Breast Cancer UK launched its “Unlocking Lobular James Lind Alliance Priority Setting Partnership Survey.” The survey aims to bring patients, carers, and healthcare professionals together to identify the most important unanswered questions about ILC and help inform future research priorities. Learn more about the partnership.
Event recordings and video highlights will be available online soon!